Nitrous oxide

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for use only by or under the supervision of a licensed practitioner who is experienced in the administration of gas mixtures. It is essential that the practitioner is familiar with the indications, effects, dosages, methods, frequency, and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Limitations of use include the potential hazards associated with the administration of this gas mixture, which may be contraindicated in certain situations. There are no teratogenic or nonteratogenic effects reported for this drug.

Dosage and Administration

Administration of the gas mixture is to be conducted via the respiratory route through inhalation. The formulation consists of 500 mL of nitrous oxide and 500 mL of oxygen, totaling 1 L of the gas mixture.

It is imperative that the administration of this gas mixture is performed by or under the supervision of a licensed practitioner who possesses experience in the use and administration of gas mixtures. This ensures the safety and efficacy of the treatment, as well as adherence to appropriate clinical guidelines.

Contraindications

Administration of this gas mixture is contraindicated in situations where safety precautions have not been fully understood and implemented. It is essential to use only equipment that has been properly cleaned for oxygen service.

Additionally, the valve should be opened slowly, and it must be closed after each use and when empty to prevent hazards. Exposure to sunlight is contraindicated when the ambient temperature exceeds 52°C (125°F) due to the risk of increased pressure and potential hazards associated with the gas mixture.

Warnings and Precautions

Administration of this gas mixture may pose significant hazards and is contraindicated in certain situations. It is imperative that this gas mixture is used solely by or under the supervision of a licensed practitioner who possesses experience in the use and administration of gas mixtures. The practitioner must be well-versed in the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Fire and Explosion Risks This gas mixture is classified as an oxidizer and may cause or intensify fire. It is stored under pressure and poses a risk of explosion if subjected to heat. Additionally, exposure to this gas may lead to increased respiration and heart rate.

Safety Precautions Prior to handling this gas mixture, it is essential that all safety precautions are thoroughly read and understood. The gas should be stored away from clothing and other combustible materials. Valves and fittings must be kept free from grease and oil to prevent any potential hazards.

This gas mixture should only be used and stored outdoors or in a well-ventilated area. A backflow preventive device must be utilized in the piping to ensure safety. Equipment used with this gas must be constructed from compatible materials and rated for cylinder pressure. Furthermore, only equipment that has been cleaned for oxygen service should be employed.

When opening the valve, it should be done slowly, and the valve must be closed after each use and when the cylinder is empty. Protection from sunlight is necessary when ambient temperatures exceed 52°C (125°F). It is crucial to read and follow the Safety Data Sheet (SDS) prior to use.

First Aid Measures In the event of accidental inhalation, the affected individual should be removed to fresh air and kept comfortable for breathing. Medical advice or attention should be sought immediately.

Side Effects

The administration of a nitrous oxide and oxygen mix may lead to several adverse reactions, which can vary in seriousness and frequency.

Serious adverse reactions include the potential for increased respiration and heart rate, which may pose risks to certain patients. Additionally, the gas mixture is classified as an oxidizer, which carries a DANGER warning due to its ability to cause or intensify fire. It is also important to note that the gas is contained under pressure, and there is a risk of explosion if heated.

Due to the potential hazards associated with the use of this gas mixture, it is contraindicated in certain situations. Administration should only be performed by or under the supervision of a licensed practitioner who possesses experience in the use and administration of gas mixtures. This practitioner must be knowledgeable about the indications, effects, dosages, methods, frequency, duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be closely monitored for any adverse reactions during and after administration to ensure safety and efficacy.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

The table below lists all NDC Code configurations of Nitrous Oxide Oxygen Mix, the U.S. brand-name prescription product. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric use of Nitrous Oxide Oxygen Mix is not specifically addressed in the available prescribing information. The insert does not provide recommended ages, dosing differences, safety concerns, or special precautions for pediatric patients, including children and adolescents. Therefore, healthcare professionals should exercise caution and consider the lack of specific data when administering this product to pediatric populations.

Geriatric Use

Geriatric patients have not been specifically addressed in the provided text regarding the use of this medication. There are no recommended age considerations, dosage adjustments, safety concerns, or special precautions outlined for elderly patients. Therefore, healthcare providers should exercise clinical judgment when prescribing this medication to geriatric patients, taking into account individual patient factors and potential comorbidities. Monitoring for efficacy and safety in this population is advised, as the absence of specific data does not preclude the need for careful assessment.

Pregnancy

Administration of this gas mixture may pose hazards or be contraindicated during pregnancy. It is essential that this gas mixture is used only by or under the supervision of a licensed practitioner who has experience in the use and administration of gas mixtures, particularly in pregnant patients. Healthcare professionals should carefully consider the potential risks and benefits before administering this gas mixture to pregnant individuals.

Lactation

There are no specific statements or considerations provided regarding nursing mothers or lactation in the prescribing information. Therefore, the effects on breastfed infants and the excretion of the drug in breast milk remain undetermined. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers.

Renal Impairment

There is no specific information regarding renal impairment, dosage adjustments, special monitoring, or safety considerations for patients with reduced kidney function provided in the insert. Healthcare professionals should exercise caution when prescribing to patients with renal impairment, as the absence of detailed guidance necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of Nitrous Oxide Oxygen Mix. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for this patient population. It is recommended that healthcare providers exercise caution and consider the overall clinical context when administering this agent to patients with compromised liver function.

Overdosage

There is currently no specific information available regarding overdosage for this medication. In the absence of documented overdosage data, healthcare professionals are advised to exercise caution and monitor patients closely for any unusual symptoms or adverse effects that may arise following administration.

In the event of suspected overdosage, it is recommended that healthcare providers initiate supportive care and symptomatic treatment as necessary. Continuous monitoring of vital signs and clinical status is essential to ensure patient safety.

Healthcare professionals should also consider consulting a poison control center or relevant toxicology resources for guidance on management strategies tailored to the specific circumstances of the overdosage event.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: nausea, vomiting, dizziness, and headache. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients that the administration of this gas mixture may pose hazards or be contraindicated. It is essential that this gas mixture is used only by or under the supervision of a licensed practitioner who is experienced in its use and administration. Patients should be informed that the practitioner must be familiar with the indications, effects, dosages, methods, frequency and duration of administration, as well as the associated hazards, contraindications, side effects, and necessary precautions.

Patients should be made aware of the potential dangers associated with this gas mixture, including that it may cause or intensify fire, as it is classified as an oxidizer. They should also be informed that the gas is stored under pressure and may explode if heated.

It is crucial to instruct patients not to handle the gas mixture until they have read and understood all safety precautions. They should be advised to keep and store the gas away from clothing and other combustible materials, and to ensure that valves and fittings are free from grease and oil. Patients should be reminded to use and store the gas only outdoors or in a well-ventilated area.

Healthcare providers should emphasize the importance of using a backflow preventive device in the piping and to utilize equipment made of compatible materials that are rated for cylinder pressure. Additionally, patients should be informed that only equipment cleaned for oxygen service should be used with this gas mixture.

Patients should be instructed to open the valve slowly and to close the valve after each use and when the cylinder is empty. They should also be cautioned to protect the gas from sunlight when the ambient temperature exceeds 52°C (125°F).

Finally, healthcare providers should recommend that patients read and follow the Safety Data Sheet (SDS) before use. In the event of accidental inhalation, patients should be advised to remove themselves to fresh air and keep comfortable for breathing, and to seek medical advice or attention promptly.

Storage and Handling

The product is supplied in configurations that ensure safe handling and storage. It is essential to keep the product away from clothing and other combustible materials to prevent fire hazards. Valves and fittings must be maintained free from grease and oil to ensure safe operation.

For optimal safety, the product should be used and stored exclusively outdoors or in a well-ventilated area. A backflow preventive device should be utilized in the piping to prevent contamination. Equipment used with the product must be made of compatible materials of construction and rated for cylinder pressure, and it should be cleaned specifically for oxygen service.

When handling the product, the valve should be opened slowly, and it is crucial to close the valve after each use and when the cylinder is empty. Additionally, protection from sunlight is necessary when the ambient temperature exceeds 52°C (125°F) to maintain product integrity.

Additional Clinical Information

The route of administration for the medication is via respiratory inhalation. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

FDA Insert (PDF)

This document is the official FDA-approved prescribing information for Nitrous Oxide Oxygen Mix as submitted by Roberts Oxygen Company, Inc.. It includes detailed information about indications, dosage, contraindications, warnings, and clinical pharmacology.

View full prescribing information (PDF)